RE-CIRCUIT® Study
Video commentary by Professor Jӧrg Kreuzer

Professor Jӧrg Kreuzer, Vice President Medicine, Therapeutic Area Cardiovascular, Boehringer Ingelheim discusses the RE-CIRCUIT® data presented at ACC17 and Boehringer Ingelheim’s commitment to advancing anticoagulation care for atrial fibrillation (AF) patients including those undergoing catheter ablation.

More related content

No results found